174 related articles for article (PubMed ID: 20705092)
21. Cytokine pharmacogenetics.
Maxwell JR; Wilson AG
Cytokine; 2006 Mar; 33(6):362-6. PubMed ID: 16529939
[TBL] [Abstract][Full Text] [Related]
22. Genetic causes of epilepsy.
Sánchez-Carpintero Abad R; Sanmartí Vilaplana FX; Serratosa Fernández JM
Neurologist; 2007 Nov; 13(6 Suppl 1):S47-51. PubMed ID: 18090951
[TBL] [Abstract][Full Text] [Related]
23. Ion Channels in Genetic Epilepsy: From Genes and Mechanisms to Disease-Targeted Therapies.
Oyrer J; Maljevic S; Scheffer IE; Berkovic SF; Petrou S; Reid CA
Pharmacol Rev; 2018 Jan; 70(1):142-173. PubMed ID: 29263209
[TBL] [Abstract][Full Text] [Related]
24. Single-gene models of epilepsy.
Noebels JL
Adv Neurol; 1999; 79():227-38. PubMed ID: 10514817
[TBL] [Abstract][Full Text] [Related]
25. [Advances in the studies on the molecular and genetic aspects of epilepsy].
Wang X; Wang T; Yuan MX; Liu MG; Wang Q
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Jun; 27(3):388-93. PubMed ID: 16038283
[TBL] [Abstract][Full Text] [Related]
26. Pharmacogenetics in neuropsychiatric diseases: epilepsy as a model.
Depondt C
Acta Neurol Belg; 2006 Dec; 106(4):157-67. PubMed ID: 17323833
[TBL] [Abstract][Full Text] [Related]
27. [Genetic diagnosis for epilepsy].
Sugawara T; Kaneko S
Nihon Rinsho; 2014 May; 72(5):834-8. PubMed ID: 24912283
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetic, pharmacodynamic, and pharmacogenetic targeted therapy of antiepileptic drugs.
Anderson GD
Ther Drug Monit; 2008 Apr; 30(2):173-80. PubMed ID: 18367977
[TBL] [Abstract][Full Text] [Related]
29. Migraine and epilepsy: genetically linked?
Haan J; van den Maagdenberg AM; Brouwer OF; Ferrari MD
Expert Rev Neurother; 2008 Sep; 8(9):1307-11. PubMed ID: 18759542
[TBL] [Abstract][Full Text] [Related]
30. Plasticity of antiepileptic drug targets.
Beck H
Epilepsia; 2007; 48 Suppl 1():14-8. PubMed ID: 17316408
[TBL] [Abstract][Full Text] [Related]
31. [Advances in the physiopathology of epileptogenesis: molecular aspects].
Armijo JA; Valdizán EM; De Las Cuevas I; Cuadrado A
Rev Neurol; 2002 Mar 1-15; 34(5):409-29. PubMed ID: 12040510
[TBL] [Abstract][Full Text] [Related]
32. [Is a gene therapy for diabetic syndromes foreseeable?].
Assan R; Clauser E; Larger E
Diabete Metab; 1994; 20(2 Pt 2):240-50. PubMed ID: 8001711
[TBL] [Abstract][Full Text] [Related]
33. [Genetic aspects of epilepsy: current knowledge and perspectives].
Malafosse A; Moulard B
Rev Neurol (Paris); 2002 Mar; 158(3):283-91. PubMed ID: 11976587
[TBL] [Abstract][Full Text] [Related]
34. Pharmacogenomics of osteoporosis: opportunities and challenges.
Nguyen TV; Eisman JA
J Musculoskelet Neuronal Interact; 2006; 6(1):62-72. PubMed ID: 16675890
[TBL] [Abstract][Full Text] [Related]
35. The impact of genetics on the classification of epilepsy syndromes.
Zara F; Bianchi A
Epilepsia; 2009 May; 50 Suppl 5():11-4. PubMed ID: 19469839
[TBL] [Abstract][Full Text] [Related]
36. Genetics of drug resistance.
Sisodiya SM
Epilepsia; 2005; 46 Suppl 10():33-8. PubMed ID: 16359469
[TBL] [Abstract][Full Text] [Related]
37. Nucleic acid-based modulation of cardiac gene expression for the treatment of cardiac diseases. Approaches and perspectives.
Poller W; Fechner H; Kurreck J; Pauschinger M; Kühl U; Erdmann VA; Lamers JM; Schultheiss HP
Z Kardiol; 2004 Mar; 93(3):171-93. PubMed ID: 15024585
[TBL] [Abstract][Full Text] [Related]
38. Adenovirus-mediated transfer of a functional GAD gene into nerve cells: potential for the treatment of neurological diseases.
Robert JJ; Bouilleret V; Ridoux V; Valin A; Geoffroy MC; Mallet J; Le Gal La Salle G
Gene Ther; 1997 Nov; 4(11):1237-45. PubMed ID: 9425448
[TBL] [Abstract][Full Text] [Related]
39. Somatic gene therapy. Present situation and future perspective.
Gottschalk U; Chan S
Arzneimittelforschung; 1998 Nov; 48(11):1111-20. PubMed ID: 9850435
[TBL] [Abstract][Full Text] [Related]
40. [Genetic aspects of epilepsy].
Kjeldsen MJ; Sørensen TT; Friis ML
Nord Med; 1996 Oct; 111(8):275-8. PubMed ID: 8966108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
